Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1990-01-03
1992-04-21
Brown, Johnnie R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 45, 536 24, 536 26, A61K 3170
Patent
active
051068370
ABSTRACT:
Novel adenine derivatives whose structures are represented by Formula I, are disclosed, as are methods of using those compounds and others of Formula II to treat monocyte-mediated disorders and autoimmune diseases.
REFERENCES:
patent: 3472838 (1969-10-01), Hanessian
patent: 3539550 (1970-11-01), Greenberg et al.
patent: 4751221 (1988-06-01), Watanabe et al.
patent: 4826823 (1989-05-01), Cook et al.
Carrera et al., J. Clin. Invest. 86:1480-1488 (Nov. 1990).
Priebe et al., Chemical Abstracts, 109(19):573, No. 168710z (1988).
Priebe et al., Cancer Research, 48:4799-4803 (Sep. 1, 1988).
Montgomery et al., J. Med. Chem., 29:2389-2392 (Nov. 1986).
Matsuda et al., Chemical Abstracts, 107:725-726, No. 97042d; [Nucleic Acids Symp. Ser., 141-143] (1987).
Christensen et al., J. Med. Chem., 15:735-739 (1972).
Kahn et al., Nucleic Acids Res., 13:6331-6342 (1985).
Parsons et al., Chemical Abstracts, 106:17, No. 60777a (1987).
Parsons et al., [Biochem. Pharmacol., 35:4025-4029 (1986)].
Morin, Tet. Letters, 24:53-56 (1983).
European Supplemental Search.
Kochetokov et al., "Organic Chemistry of Nucleic Acids", Part B, p. 335, Plenum Press (1972).
Dictionary of Microbiology and Molecular Biology, Second Edition, Singleton and Sainsbury, Wiley & Sons, pp. 513, 562, 563.
Carrera Carlos J.
Carson Dennis A.
Brown Johnnie R.
Crane L. Eric
The Scripps Research Institute
LandOfFree
Adenosine derivatives with therapeutic activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Adenosine derivatives with therapeutic activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Adenosine derivatives with therapeutic activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1586274